仟源医药: 山西仟源医药集团股份有限公司2025年度限制性股票激励计划自查表

Group 1 - Company Name: Shanxi Qianyuan Pharmaceutical Group Co., Ltd. [1] - Stock Code: 300254 [1] - Independent Financial Advisor: Shanghai Rongzheng Enterprise Consulting Service (Group) Co., Ltd. [1] Group 2 - Compliance with Listing Company Requirements: No negative or unable to express opinions in the audit report for the most recent financial year [3] - No violations of laws, regulations, or company articles regarding profit distribution in the last 36 months [3] - No major legal violations leading to administrative penalties or market bans by the China Securities Regulatory Commission in the last 12 months [3] Group 3 - Stock Incentive Plan Compliance: Total number of shares involved in all effective stock incentive plans does not exceed 20% of the company's total share capital [4] - The proportion of reserved rights for incentive objects does not exceed 20% of the proposed granted rights [4] - The plan includes detailed disclosures regarding the incentive objects, including names, positions, and granted quantities [4][5] Group 4 - Performance Assessment Indicators: Indicators are objective, public, clear, and beneficial for enhancing the company's competitiveness [5] - The plan's effective period, authorization date, and lock-up arrangements are clearly defined [4][6] - The company has not provided financial assistance to incentive objects [8]